The functional domains of dopamine transporter for cocaine analog, CFT binding

被引:7
|
作者
Lee, SH
Chang, MY
Jeon, DJ
Oh, DY
Son, H
Lee, CH
Lee, YS
Lee, YS
机构
[1] Hanyang Univ, Coll Med, Dept Biochem, Seoul 133791, South Korea
[2] Hanyang Univ, Mental Hlth Res Inst, Seoul 133791, South Korea
[3] Natl Seoul Mental Hosp, Seoul, South Korea
来源
EXPERIMENTAL AND MOLECULAR MEDICINE | 2002年 / 34卷 / 01期
关键词
dopamine transporter (DAT); cocaine; cocaine binding; CFT; CFT binding; transmembrane domain;
D O I
10.1038/emm.2002.13
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cocaine analogue, CFT (2beta-carbomethoxy-3beta-(4-fluorophenyl) tropane) binding to dopamine transporter (DAT) in different species is quite heterogeneous. CFT is scarcely detected in bovine DAT whereas it is conspicuous in humans. To examine the structural basis for this functional discrepancy, we analyzed transporter chimeras of these two DATs. The CFT binding activities are avid in all of the chimeric DATs of which both of the 3(rd) and the 6-8(th) transmembrane domain (TM) are composed of human DAT sequences. On the contrary, CFT binding activities were scarcely detected if either or both of two regions are replaced with bovine sequences. These findings indicate that the CFT binding absolutely requires human DAT sequences, at least, in the regions encompassing the 3(rd) and 6-8(th) transmembrane domain (TM), and that these regions might contribute to form the 3-dimensional pocket for CFr binding.
引用
收藏
页码:90 / 94
页数:5
相关论文
共 50 条
  • [31] PET imaging of cocaine binding sites on the dopamine transporter: An application for cocaine medications development.
    Madras, BK
    Livni, E
    Elmaleh, DR
    Fischman, AJ
    Brownell, AL
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 251 - 251
  • [32] PRENATAL COCAINE EXPOSURE - DECREASED SENSITIZATION TO COCAINE AND DECREASED STRIATAL DOPAMINE TRANSPORTER BINDING IN OFFSPRING
    BYRNES, JJ
    PRITCHARD, GA
    KOFF, JM
    MILLER, LG
    NEUROPHARMACOLOGY, 1993, 32 (07) : 721 - 723
  • [33] CLONING AND FUNCTIONAL-CHARACTERIZATION OF A COCAINE-SENSITIVE DOPAMINE TRANSPORTER
    GIROS, B
    ELMESTIKAWY, S
    BERTRAND, L
    CARON, MG
    FEBS LETTERS, 1991, 295 (1-3): : 149 - 154
  • [34] Dopamine Transporter-Dependent and -Independent Striatal Binding of the Benztropine Analog JHW 007, a Cocaine Antagonist with Low Abuse Liability
    Kopajtic, Theresa A.
    Liu, Yi
    Surratt, Christopher K.
    Donovan, David M.
    Newman, Amy H.
    Katz, Jonathan L.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (03): : 703 - 714
  • [35] EVIDENCE FOR MUTUALLY EXCLUSIVE BINDING OF COCAINE, BTCP, GBR-12935, AND DOPAMINE TO THE DOPAMINE TRANSPORTER
    REITH, MEA
    DECOSTA, B
    RICE, KC
    JACOBSON, AE
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (04): : 417 - 425
  • [36] Discordant increases in [H-3]CFT and [I-125]beta-CIT binding to striatal dopamine transporter in human cocaine users
    Little, KY
    Zhang, L
    McFinton, PR
    Mulrooney, SB
    DelProposto, ZS
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 18 - 18
  • [37] Syntheses of novel cocaine antagonists: Examination of binding and uptake at the dopamine transporter.
    Adejare, A
    Day, MS
    Ahmed, MS
    Brown, PW
    Lau, V
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U576 - U576
  • [38] ISOTHIOCYANATE DERIVATIVES OF COCAINE - IRREVERSIBLE INHIBITION OF LIGAND-BINDING AT THE DOPAMINE TRANSPORTER
    BOJA, JW
    RAHMAN, MA
    PHILIP, A
    LEWIN, AH
    CARROLL, FI
    KUHAR, MJ
    MOLECULAR PHARMACOLOGY, 1991, 39 (03) : 339 - 345
  • [39] Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter
    Houlihan, WJ
    Boja, JW
    Parrino, VA
    Kopajtic, TA
    Kuhar, MJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) : 4935 - 4941
  • [40] Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine
    Katz, JL
    Newman, AH
    Izenwasser, S
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (03) : 505 - 512